| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 80.61B | 80.27B | 85.53B | 93.94B | 101.56B | 85.25B |
| Gross Profit | 4.70B | 5.03B | 5.78B | 7.51B | 7.57B | 5.99B |
| EBITDA | 3.48B | 3.05B | 4.10B | 6.00B | 6.66B | 4.57B |
| Net Income | 1.08B | 1.08B | 1.80B | 3.48B | 4.34B | 2.71B |
Balance Sheet | ||||||
| Total Assets | 55.60B | 34.66B | 53.27B | 54.63B | 59.77B | 56.14B |
| Cash, Cash Equivalents and Short-Term Investments | 624.00M | 1.05B | 857.00M | 1.37B | 1.04B | 943.00M |
| Total Debt | 10.66B | 8.41B | 11.54B | 9.60B | 10.29B | 10.58B |
| Total Liabilities | 32.49B | 11.63B | 30.84B | 30.17B | 35.16B | 33.37B |
| Stockholders Equity | 22.80B | 22.73B | 22.17B | 24.13B | 24.28B | 22.48B |
Cash Flow | ||||||
| Free Cash Flow | 4.79B | 4.20B | 1.23B | 2.97B | 2.16B | 5.43B |
| Operating Cash Flow | 5.94B | 5.45B | 2.79B | 4.46B | 3.48B | 6.59B |
| Investing Cash Flow | -1.02B | -1.02B | -2.70B | -1.50B | -1.40B | -2.67B |
| Financing Cash Flow | -2.86B | -2.89B | -1.53B | -4.60B | -2.50B | -1.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $3.71B | 20.41 | 26.11% | 10.53% | -8.85% | -29.16% | |
78 Outperform | $10.26B | 10.87 | 15.25% | 4.44% | 8.00% | -1.43% | |
68 Neutral | $37.38B | 29.52 | 4.78% | 3.55% | -3.82% | -20.58% | |
63 Neutral | $23.27B | 90.61 | 4.47% | 3.14% | 56.89% | -45.77% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | $22.96B | 21.70 | 2.50% | 3.48% | 3.91% | -50.15% | |
57 Neutral | $1.56B | 45.63 | 3.43% | 3.34% | 0.22% | -52.50% |